Tentative US approval for Merck’s diabetes therapy

21st July 2017 Uncategorised 0

The US Food and Drug Administration has given a tentative green light to Merck & Co’s follow-on biologic basal insulin Lusduna Nexvue.

More: Tentative US approval for Merck’s diabetes therapy
Source: News